


Ventas Seeking Investment Partners
In what we would call a change in strategy for a healthcare REIT, Ventas is launching a new “growth platform,” called the Ventas Life Science and Healthcare Real Estate Fund, L.P. They are calling it a “perpetual life vehicle” that will focus its investments in core and core-plus life science, medical office and seniors housing real estate. It will officially launch late this quarter, and it will have $700 million in assets under management, and they have third-party equity commitments for about $650 million, so far. Ventas will be the fund sponsor and general partner, expecting to hold a 20% ownership stake and participating in the future cash flows. Ventas EVP... Read More »
Blueprint Handles Two More REIT Sales
The closings keep coming from Blueprint Healthcare Real Estate Advisors, as the firm has announced a series of acquisitions in the last couple weeks of the year, mainly for publicly-traded REIT clients. Ben Firestone, Michael Segal, Alex Florea and Scott Frazier first teamed up to sell an assisted living/memory care community in Escondido, California (an affluent suburb of San Diego). Previously owned by an LLC affiliated with Ventas, the community was originally built in 1986 and expanded with a new independent living building in 2006. Initially, the community offered a full spectrum of care from independent living to skilled nursing. However, the new IL building was converted to... Read More »
Of Ventas, Welltower and NIC
I know as one gets older, confusion can become more common. And today, I am a little confused about the state of the senior living industry. -Sponsored by The Senior Care Acquisition Reports NIC MAP has reported that maybe we have hit bottom in the third quarter, and that new construction starts are starting to decline, even though new openings remain high. Assisted living occupancy, while posting a small sequential increase, still remains far too low to get excited, but bottoming out would be welcome news. Then, Ventas reported its third quarter earnings, painting a not-so-pretty picture. Their RIDEA operating portfolio has not been performing well, posting a 5.0% decline in... Read More »